The call that notified Bertozzi, professor of chemistry at Stanford University, that she had been awarded the 2022 Nobel Prize in Chemistry for her role in developing bioorthogonal reactions, which enable scientists to explore cells and track biological processes without interfering with the normal chemistry of the cell.
Bioorthogonal chemistry is being applied to cancer treatment by José M. Mejía Oneto, MD, PhD, CEO of Shasqi Inc., which has developed a way to safely deliver high doses of chemotherapy without impacting nearby tissues.
